Project 170482

Characterization of B cell tolerance and functional abnormalities in human lupus

170482

Characterization of B cell tolerance and functional abnormalities in human lupus

$363,714
Project Information
Study Type: Basic_Research Mechanistic_Study
Therapeutic Area: Rheumatology
Research Theme: Biomedical
Disease Area: systemic lupus erythematosus
Data Type: Experimental
Institution & Funding
Principal Investigator(s): Wither, Joan E
Institution: University Health Network (Toronto)
CIHR Institute: Infection and Immunity
Program: Operating Grant
Peer Review Committee: Immunology & Transplantation
Competition Year: 2008
Term: 3 yrs 0 mth
Abstract Summary

The immune system plays an important role in discriminating between proteins that are foreign to the body, such as those in the bacteria and viruses that cause infections, and proteins that are normal parts of the body, such as those found in organs like the kidney and the brain. Foreign proteins are attacked preventing overwhelming infection while self-proteins are normally left unharmed. We believe that Systemic Lupus Erythematosus (SLE) results from defects in the immune system that lead to abnormal activation of cells that react to self-proteins. In the immune system two classes of cells, T and B cells, act in concert to mount an immune response. In many strains of mice that develop a lupus-like illness, B cell functional abnormalities play a central role in the pathogenesis of disease, yet the function of B cells in human lupus has not been well explored. Nevertheless, we, and others have shown that the B cells of humans with lupus are abnormally activated suggesting that they too have altered function. Here we seek to identify the functional abnormalities in the B cells of lupus patients and to determine whether they lead to altered responses to self-proteins. Identification of such abnormalities could ultimately lead to characterization of the underlying biochemical and genetic defects that produce SLE and more effective therapies for this condition.

Research Characteristics

This project includes the following research characteristics:

Biomarker Endpoints
Composite Endpoint
Vulnerable Populations
Rare Disease
Study Justification

"identification of functional abnormalities could ultimately lead to characterization of the underlying biochemical and genetic defects that produce SLE and more effective therapies for this condition"

Novelty Statement

"identify functional abnormalities in B cells of lupus patients and determine whether they lead to altered responses to self-proteins"

Keywords
Autoimmunity B Cells Lupus Tolerance